Spyre Therapeutics, Inc. (SYRE)
69.70
+0.71
(+1.03%)
USD |
NASDAQ |
Apr 16, 16:00
70.14
+0.44
(+0.63%)
After-Hours: 05:15
Spyre Therapeutics Free Cash Flow : -169.41M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tyra Biosciences, Inc. | -95.28M |
| Savara, Inc. | -101.06M |
| Agios Pharmaceuticals, Inc. | -377.29M |
| Tandem Diabetes Care, Inc. | -29.67M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.65M |
| Cash from Investing (Quarterly) | -247.41M |
| Cash from Financing (Quarterly) | 312.88M |
| Free Cash Flow Per Share (Quarterly) | -0.5946 |
| Free Cash Flow to Equity (Quarterly) | -44.65M |
| Free Cash Flow to Firm (Quarterly) | -44.65M |
| Free Cash Flow Yield | -3.79% |